Baxter Reports $45M Boost From COVID-19 Demand In Q1

 
• By Reed Miller

The COVID-19 pandemic has increased demand for products from all of Baxter’s businesses except its advanced surgery division. Overall, the diversified company’s global sales were up 8% in the first quarter.

COVID-19 Coronavirus outbreak financial crisis help policy, company and business to survive concept, businessman leader help pushing bar graph falling in economic collapse from COVID-19 virus pathogen
• Source: shutterstock.com

More from Business

More from Medtech Insight